InvestorsHub Logo
Followers 114
Posts 8717
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Friday, 05/08/2020 4:27:29 PM

Friday, May 08, 2020 4:27:29 PM

Post# of 710681

Carlo Rago
@rago_carlo
·
53m
Dendtric cell vaccine mOS results improved with TLR agonists (2018 reminder):

adjuvant poly ICLC = 54 months
adjuvant resiquimod = 19 months
SOC = 11 months

$NWBO #DCVax #GBM
$BMY $MRK $BMY $AZN
ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN...
Abstract. Despite advances in the understanding of glioblastoma multiforme (GBM) molecular biology, genomics, and tumor microenvironment, prognosis for patient
academic.oup.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News